First Trust Advisors LP Lowers Position in Cigna Group $CI

First Trust Advisors LP trimmed its position in shares of Cigna Group (NYSE:CI) by 13.7% during the 1st quarter, HoldingsChannel.com reports. The fund owned 217,766 shares of the health services provider’s stock after selling 34,430 shares during the period. First Trust Advisors LP’s holdings in Cigna Group were worth $58,089,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Cigna Group by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after purchasing an additional 414,834 shares during the period. State Street Corp boosted its position in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after purchasing an additional 224,122 shares in the last quarter. Massachusetts Financial Services Co. MA grew its stake in Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after purchasing an additional 903,334 shares during the period. Dodge & Cox grew its stake in Cigna Group by 19.7% in the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Finally, GQG Partners LLC raised its holdings in Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of a number of recent research reports. Sanford C. Bernstein upped their target price on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Jefferies Financial Group dropped their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Guggenheim upped their price objective on shares of Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Finally, Wells Fargo & Company raised their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Price Performance

Shares of NYSE:CI opened at $290.06 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The business has a fifty day moving average price of $286.05 and a 200-day moving average price of $280.78. The company has a market capitalization of $76.73 billion, a PE ratio of 12.30, a PEG ratio of 1.12 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.45%.

Insider Buying and Selling

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.